Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ricinelaidic acid is a 12-hydroxy fatty acid and an antagonist of leukotriene B4 (LTB4) receptors (Ki = 2 μM in porcine neutrophil membranes). It inhibits chemotaxis and calcium flux induced by LTB4 in isolated human neutrophils (IC50s = 10 and 7 μM, respectively). Ricinelaidic acid (1 mg/kg, i.v.) inhibits bronchoconstriction induced by LTB4 in rats by 46%.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
100 mg | 35 days | $ 540.00 | |
250 mg | 35 days | $ 1,190.00 |
Description | Ricinelaidic acid is a 12-hydroxy fatty acid and an antagonist of leukotriene B4 (LTB4) receptors (Ki = 2 μM in porcine neutrophil membranes). It inhibits chemotaxis and calcium flux induced by LTB4 in isolated human neutrophils (IC50s = 10 and 7 μM, respectively). Ricinelaidic acid (1 mg/kg, i.v.) inhibits bronchoconstriction induced by LTB4 in rats by 46%. |
Molecular Weight | 298.46 |
Formula | C18H34O3 |
CAS No. | 540-12-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ethanol: Miscible
DMF: 3 mg/mL
DMSO: 2 mg/mL
PBS (pH 7.2): 2 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ricinelaidic Acid 540-12-5 inhibitor inhibit